Handling deviating control values in concentration-response curves

Abstract

In cell biology, pharmacology and toxicology dose-response and concentration-response curves are frequently fitted to data with statistical methods. Such fits are used to derive quantitative measures (e.g. EC$$_{20}$$ 20 values) describing the relationship between the concentration of a compound or the strength of an intervention applied to cells and its effect on viability or function of these cells. Often, a reference, called negative control (or solvent control), is used to normalize the data. The negative control data sometimes deviate from the values measured for low (ineffective) test compound concentrations. In such cases, normalization of the data with respect to control values leads to biased estimates of the parameters of the concentration-response curve. Low quality estimates of effective concentrations can be the consequence. In a literature study, we found that this problem occurs in a large percentage of toxicological publications. We propose different strategies to tackle the problem, including complete omission of the controls. Data from a controlled simulation study indicate the best-suited problem solution for different data structure scenarios. This was further exemplified by a real concentration-response study. We provide the following recommendations how to handle deviating controls: (1) The log-logistic 4pLL model is a good default option. (2) When there are at least two concentrations in the no-effect range, low variances of the replicate measurements, and deviating controls, control values should be omitted before fitting the model. (3) When data are missing in the no-effect range, the Brain-Cousens model sometimes leads to better results than the default model.

Elucidating Design Principles for Engineering Cell‐Derived Vesicles to Inhibit SARS‐CoV‐2 Infection

“…In flow cytometry experiments evaluating the dose‐response curves of viral inhibitors, the percent of transduced cells for a given treatment was normalized by the percent of transduced cells determined from that treatment's largest dilution as depicted in Figure S5 , Supporting Information. [ 74 ] Curves were then fit with a four parameter, nonlinear regression in GraphPad Prism 9.2. Convergence criterion was set to “Strict” with 10 000 maximum iterations, and the regression was constrained as follows: “Bottom” = 0, “Top” = 100, “IC50” > 0.…”

Establishment of a Human Cell-Based in Vitro Battery to Assess Developmental Neurotoxicity Hazard of Chemicals

“…The best-fitting model (general logistic, was selected by the AKAIKE information criteria (Ritz et al, 2015;Jensen et al, 2020). ( 5) Re-normalization of the data, so that the upper asymptote of the selected curve fit was at 100% (Krebs et al, 2018;Kappenberg et al, 2020). ( 6) Calculation of the mean re-normalized values for each condition across independent test runs.…”

Elucidating design principles for engineering cell-derived vesicles to inhibit SARS-CoV-2 infection

“…In dose-response curve experiments, the percent of transduced cells for a given treatment was normalized by the percent of transduced cells determined from that treatment’s largest dilution as depicted in Figure S5 . 54 Curves were then fit with a four parameter, nonlinear regression in GraphPad Prism 9.2. Convergence criteria was set to “Strict” with 10,000 maximum iterations, and the regression was constrained as follows: “Bottom” = 0, “Top” = 100, “IC50” > 0.…”